RT Journal Article SR Electronic T1 Associations between Single Nucleotide Polymorphisms of MMP2, VEGF, and HIF1A Genes and the Risk of Developing Colorectal Cancer JF Anticancer Research JO Anticancer Res FD International Institute of Anticancer Research SP 575 OP 584 VO 31 IS 2 A1 MIN-JUNG KANG A1 SUNG-AE JUNG A1 JI MIN JUNG A1 SEONG-EUN KIM A1 HYE-KYUNG JUNG A1 TAE-HUN KIM A1 KI-NAM SHIM A1 SUN YOUNG YI A1 KWON YOO A1 IL HWAN MOON YR 2011 UL http://ar.iiarjournals.org/content/31/2/575.abstract AB The aim of this study was to investigate the association between the risk for colorectal cancer and single nucleotide polymorphisms (SNP) of matrix metalloproteinase-2 (MMP2) -1306C/T, vascular endothelial growth factor (VEGF) 936C/T and hypoxia inducible factor-1α (HIF1A) 1772C/T. Patients and Methods: A total 50 colorectal cancer patients (46% women, mean age 68±11 years) were enrolled. Healthy controls without evidence of cancer history or family cancer predispositions were frequency-matched to the cases by sex and age (±5 years). Genotyping was performed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method and the genotype distribution and risk estimate were analyzed. The correlation between the genotypes and clinicopathological parameters (Dukes stage, phenotype, location, differentiation and size) among colorectal cancer patients were investigated. Results: There was a significant association between colorectal cancer and T allele-bearing genotype distribution of HIF1A 1772C/T polymorphism (Odds ratio, OR=3.63, 95% confidence interval, CI=1.08-12.18, p=0.03 for CT and TT genotypes relative to CC genotype). In addition, when stratified by age, the association remained in patients older than 60 years old (OR=13.60, 95% CI=1.63-113.24, p=0.01). However, there was no association between the genotypes of the MMP2, VEGF and HIF1A SNP and clinicopathological parameters of colorectal cancer. Conclusion: There is a significant association between the HIF1A 1772C/T SNP and the risk of developing colorectal cancer, especially in individuals older than 60 years.